Cargando…
Multimodal Radiobioconjugates of Magnetic Nanoparticles Labeled with (44)Sc and (47)Sc for Theranostic Application
This study was performed to synthesize multimodal radiopharmaceutical designed for the diagnosis and treatment of prostate cancer. To achieve this goal, superparamagnetic iron oxide (SPIO) nanoparticles were used as a platform for targeting molecule (PSMA-617) and for complexation of two scandium ra...
Autores principales: | Ünak, Perihan, Yasakçı, Volkan, Tutun, Elif, Karatay, K. Buşra, Walczak, Rafał, Wawrowicz, Kamil, Żelechowska-Matysiak, Kinga, Majkowska-Pilip, Agnieszka, Bilewicz, Aleksander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10053001/ https://www.ncbi.nlm.nih.gov/pubmed/36986710 http://dx.doi.org/10.3390/pharmaceutics15030850 |
Ejemplares similares
-
Nanoparticles in Targeted Alpha Therapy
por: Majkowska-Pilip, Agnieszka, et al.
Publicado: (2020) -
Platinum nanoparticles labelled with iodine-125 for combined “chemo-Auger electron” therapy of hepatocellular carcinoma
por: Wawrowicz, Kamil, et al.
Publicado: (2023) -
Oxidative Status as an Attribute for Selective Antitumor Activity of Platinum-Containing Nanoparticles against Hepatocellular Carcinoma
por: Wawrowicz, Kamil, et al.
Publicado: (2022) -
Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ Cancers
por: Żelechowska-Matysiak, Kinga, et al.
Publicado: (2023) -
Au@(109)Pd core–shell nanoparticle conjugated to trastuzumab for the therapy of HER2+ cancers: studies on the applicability of (109)Pd/(109m)Ag in vivo generator in combined β(−) auger electron therapy
por: Gharibkandi, Nasrin Abbasi, et al.
Publicado: (2023)